Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
All content for Kismet Tech Talks is the property of Kismet Technologies and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
Kismet Tech Talks
Hospital-acquired infections (HAIs) remain one of the most persistent and costly challenges in healthcare today, impacting approximately 1 in 31 hospital patients on any given day in the U.S., according to the CDC. In this episode, Kismet Technologies’ CEO Shari Costantini sits down with Microbiology Manager Kelly Ager to explore the science and results behind NanoRAD, a breakthrough surface treatment designed for continuous protection. Drawing from a recent hospital study, Kelly shares the r...
